<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02772770</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00017850</org_study_id>
    <nct_id>NCT02772770</nct_id>
  </id_info>
  <brief_title>Pediatric ACL: Understanding Treatment Options</brief_title>
  <acronym>PLUTO</acronym>
  <official_title>Pediatric ACL: Understanding Treatment Options (PLUTO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rady Children's Hospital, San Diego</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Healthcare of Atlanta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Luke's Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saint Thomas Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pediatric ACL: Understanding Treatment Outcomes (PLUTO) is a multi-center, prospective cohort
      study. Specific aims of PLUTO are to evaluate the safety and comparative effectiveness of
      non-operative treatment, as well as four operative treatments including (1) transphyseal ACL
      reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal
      ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction
      using the Micheli/Kocher technique in prepubescent and pubescent skeletally immature
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anterior Cruciate Ligament (ACL) injuries are being seen with increased frequency in
      pediatric and adolescent patients. The management of these injuries is controversial and
      includes nonoperative treatment and operative treatment with various surgical techniques.
      Pediatric ACL: Understanding Treatment Outcomes (PLUTO) is a multi-center, prospective cohort
      study. Specific aims of PLUTO are to evaluate the safety and comparative effectiveness of
      non-operative treatment, as well as four operative treatments including (1) transphyseal ACL
      reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal
      ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction
      using the Micheli/Kocher technique in prepubescent and pubescent skeletally immature
      patients. Accrual will take place over eight years at 9 pediatric sports medicine centers.
      Post-treatment outcome assessment will be performed at 6-9 months, 1 year, and 2, 5, and 10
      years after treatment , including functional outcome, activity level, health-related quality
      of life, graft survivorship, knee stability, knee motion, and growth disturbance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">May 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Knee functional outcome at 2 years post-ACL reconstruction (Pedi-IKDC)</measure>
    <time_frame>2 years</time_frame>
    <description>To compare outcomes associated with four surgical techniques performed to treat complete intrasubstance ACL tears in pre- and early pubescent children: (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life (Pediatric Quality of Life Inventory (PedsQL)</measure>
    <time_frame>2 years</time_frame>
    <description>To compare outcomes associated with four surgical techniques performed to treat complete intrasubstance ACL tears in pre- and early pubescent children: (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graft failure (MRI, Lachman, Pivot-Shift)</measure>
    <time_frame>2 years</time_frame>
    <description>To compare outcomes associated with four surgical techniques performed to treat complete intrasubstance ACL tears in pre- and early pubescent children: (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity level (P-FABS and Physical Activity Questionnaire)</measure>
    <time_frame>2 years</time_frame>
    <description>To compare outcomes associated with four surgical techniques performed to treat complete intrasubstance ACL tears in pre- and early pubescent children: (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth disturbance (angular deformity, leg length discrepancy per clinical exam and radiographs)</measure>
    <time_frame>2 years</time_frame>
    <description>To compare outcomes associated with four surgical techniques performed to treat complete intrasubstance ACL tears in pre- and early pubescent children: (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Re-injury or instability requiring ACL reconstruction</measure>
    <time_frame>2 years</time_frame>
    <description>To establish outcomes associated with non-operative treatment (rehabilitation, bracing and activity restriction) used to manage complete intrasubstance ACL tears in pre- and early pubescent children.</description>
  </other_outcome>
  <other_outcome>
    <measure>Knee function (Pedi-IKDC)</measure>
    <time_frame>2 years</time_frame>
    <description>To establish outcomes associated with non-operative treatment (rehabilitation, bracing and activity restriction) used to manage complete intrasubstance ACL tears in pre- and early pubescent children.</description>
  </other_outcome>
  <other_outcome>
    <measure>Health-related quality of life (PedsQL)</measure>
    <time_frame>2 years</time_frame>
    <description>To establish outcomes associated with non-operative treatment (rehabilitation, bracing and activity restriction) used to manage complete intrasubstance ACL tears in pre- and early pubescent children.</description>
  </other_outcome>
  <other_outcome>
    <measure>Activity level ( P-FABS and Physical Activity Questionnaire)</measure>
    <time_frame>2 years</time_frame>
    <description>To establish outcomes associated with non-operative treatment (rehabilitation, bracing and activity restriction) used to manage complete intrasubstance ACL tears in pre- and early pubescent children.</description>
  </other_outcome>
  <other_outcome>
    <measure>Subsequent meniscal or chondral injury (MRI)</measure>
    <time_frame>2 years</time_frame>
    <description>To establish outcomes associated with non-operative treatment (rehabilitation, bracing and activity restriction) used to manage complete intrasubstance ACL tears in pre- and early pubescent children.</description>
  </other_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">405</enrollment>
  <condition>Anterior Cruciate Ligament Reconstruction</condition>
  <arm_group>
    <arm_group_label>Non Operative: Rehabilitation, Bracing, Activity Restriction</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative: Transphyseal</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative: Partial Transphyseal</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative: Physeal sparing by Anderson Technique</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative: Physeal sparing by Micheli/Kocher Technique</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-operative treatment group will undergo standardized treatment which will include rehabilitation, bracing and certain activity restrictions</intervention_name>
    <description>The non-operative treatment group will undergo standardized treatment which will include rehabilitation, bracing and certain activity restrictions.</description>
    <arm_group_label>Non Operative: Rehabilitation, Bracing, Activity Restriction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical technique: Transphyseal reconstruction</intervention_name>
    <description>Study physicians will have the option to treat ACL injuries operatively or non-operatively, according to their standard of care. However, once the decision is made to manage the injury operatively or non-operatively, the physician must follow the appropriate standardized treatment protocol developed for the study. The operative treatment protocol will include standardized surgical techniques for transphyseal reconstruction with soft tissue graft and metaphyseal fixation.</description>
    <arm_group_label>Operative: Transphyseal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical technique: Partial transphyseal reconstruction</intervention_name>
    <description>Study physicians will have the option to treat ACL injuries operatively or non-operatively, according to their standard of care. However, once the decision is made to manage the injury operatively or non-operatively, the physician must follow the appropriate standardized treatment protocol developed for the study. The operative treatment protocol will include partial transphyseal reconstruction (tibial transphyseal and femoral epiphyseal) with soft tissue graft.</description>
    <arm_group_label>Operative: Partial Transphyseal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical technique: Physeal sparing reconstruction by the Anderson method</intervention_name>
    <description>Study physicians will have the option to treat ACL injuries operatively or non-operatively, according to their standard of care. However, once the decision is made to manage the injury operatively or non-operatively, the physician must follow the appropriate standardized treatment protocol developed for the study. The operative treatment protocol will include standardized surgical techniques for physeal sparing epiphyseal reconstruction with soft tissue graft (Anderson technique).</description>
    <arm_group_label>Operative: Physeal sparing by Anderson Technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical technique: Physeal sparing reconstruction by the Micheli/Kocher method</intervention_name>
    <description>Study physicians will have the option to treat ACL injuries operatively or non-operatively, according to their standard of care. However, once the decision is made to manage the injury operatively or non-operatively, the physician must follow the appropriate standardized treatment protocol developed for the study. The operative treatment protocol will include physeal-sparing with Iliotibial band combined extra-articular and intra-articular reconstructions (Micheli/Kocher Technique).</description>
    <arm_group_label>Operative: Physeal sparing by Micheli/Kocher Technique</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The pool of patients for this study will be patients seen in outpatient and sports medicine
        clinics at each clinical center. The minimum accrual target for this study is 360 surgical
        patients and 45 non-operative patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of complete intrasubstance ACL tear

          -  Skeletally Immature (by knee radiographs)

          -  Age 5 to 15

        Exclusion Criteria:

          -  Prior ACL surgery on the ipsilateral knee

          -  Congenital ACL deficiency

          -  Multiple ligament reconstruction required

          -  Skeletally mature

          -  Other significant comorbidities including syndromic conditions, neuromuscular
             disorders or developmental delay

          -  If scheduling of the ACL surgery is impacted by the skeletal maturity of the patient

          -  Simultaneous bilateral ACL tears
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mininder S Kocher, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nancy S Gee, MPH</last_name>
    <phone>617-919-1764</phone>
    <email>nancy.gee@childrens.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Connell, MPH</last_name>
    <phone>617-355-4011</phone>
    <email>Patricia.Connell2@childrens.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford Children's Health</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steven Frick, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Katie Hastings</last_name>
      <email>katiegh@stanford.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rady Children's Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Edmonds, MD</last_name>
      <email>Ewedmonds@rchsd.org</email>
    </contact>
    <contact_backup>
      <last_name>Melissa Dennis</last_name>
      <email>mdennis@rchsd.org</email>
    </contact_backup>
    <investigator>
      <last_name>Hank Chambers, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Pennock, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S Clinton Willimon, MD</last_name>
      <email>cliff.willimon@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Belinda Schaafsma</last_name>
      <email>belinda.schaafsma@choa.org</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Busch, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Melissa Christino, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Children's Hospital Boise</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Shea, MD</last_name>
      <phone>208-381-0201</phone>
    </contact>
    <contact_backup>
      <last_name>Aleksei Dingel</last_name>
      <phone>208-381-0201</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mininder S Kocher, MD, MPH</last_name>
      <phone>617-355-8423</phone>
      <email>mkocher@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Benton Heyworth, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lyle Micheli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Milewksi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey J Nepple, MD</last_name>
      <email>nepplej@wudosis.wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Lauren Davis</last_name>
      <phone>314-454-5345</phone>
      <email>davisl@wudosis.wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Matthew Matava, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel W Greene, MD</last_name>
      <phone>212-606-1631</phone>
      <email>GreenDW@HSS.EDU</email>
    </contact>
    <contact_backup>
      <last_name>Colleen Wixted</last_name>
      <phone>646-714-6889</phone>
      <email>wixtedc@hss.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Peter D Fabricant, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank A Cordasco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Wall, MD</last_name>
      <email>eric.wall@cchmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Matthew Veerkamp</last_name>
      <email>Matthew.Veerkamp@cchmc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Shital Parikh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul M Saluan, MD</last_name>
      <email>saluanp@ccf.org</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Turczyj</last_name>
      <email>turczyj@ccf.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Theodore Ganley, MD</last_name>
      <email>ganley@email.chop.edu</email>
    </contact>
    <contact_backup>
      <last_name>Julien Aoyama</last_name>
      <email>AoyamaJ@email.chop.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Todd Lawrence, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tennessee Orthopaedic Alliance</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian F Anderson, MD</last_name>
      <email>andersonc@toa.com</email>
    </contact>
    <contact_backup>
      <last_name>Janet Trimble</last_name>
      <phone>615-234-7217</phone>
      <email>trimblejt@toa.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2016</study_first_submitted>
  <study_first_submitted_qc>May 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2016</study_first_posted>
  <last_update_submitted>March 21, 2018</last_update_submitted>
  <last_update_submitted_qc>March 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Mininder Kocher</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

